These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8423546)

  • 21. Blockade of neurokinin3 receptors antagonizes drug-induced population response and depolarization block of midbrain dopamine neurons in guinea pigs.
    Gueudet C; Santucci V; Soubrié P; Le Fur G
    Synapse; 1999 Jul; 33(1):71-9. PubMed ID: 10380852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.
    Blackburn TP; Suzuki K; Ashby CR
    Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study.
    Minabe Y; Matsuno K; Ashby CR
    Synapse; 1999 Aug; 33(2):129-40. PubMed ID: 10400891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinazolinone cholecystokinin (CCK)-B antagonists decrease midbrain dopamine unit activity.
    Rasmussen K; Yu MJ; Czachura JF
    Synapse; 1994 Aug; 17(4):278-82. PubMed ID: 7992203
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of acute and chronic LY 277359, a selective 5-HT3 receptor antagonist, on the number of spontaneously active midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Eur J Pharmacol; 1991 Dec; 209(3):151-6. PubMed ID: 1797560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin.
    Freeman AS; Bunney BS
    Brain Res; 1987 Mar; 405(1):46-55. PubMed ID: 3032350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal haloperidol reduces the number of active midbrain dopamine neurons in rat offspring.
    Zhang J; Wang L; Pitts DK
    Neurotoxicol Teratol; 1996; 18(1):49-57. PubMed ID: 8700043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat.
    White FJ; Wang RY
    Neuropharmacology; 1986 Sep; 25(9):995-1001. PubMed ID: 2877417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells.
    Stockton ME; Rasmussen K
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):50-6. PubMed ID: 8935800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.
    Stockton ME; Rasmussen K
    Neuropsychopharmacology; 1996 Feb; 14(2):97-105. PubMed ID: 8822532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons.
    Chiodo LA; Bunney BS
    J Neurosci; 1985 Sep; 5(9):2539-44. PubMed ID: 2863337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of forebrain microinjection of cholecystokinin on dopamine cell firing rate.
    Hamilton ME; Weddige FK; Freeman AS
    Peptides; 2001 Jul; 22(7):1063-9. PubMed ID: 11445235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the acute and chronic administration of the selective neurokinin2 receptor antagonist SR 48968 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Minabe Y; Ashby CR
    Synapse; 1997 Feb; 25(2):196-204. PubMed ID: 9021900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat.
    Olijslagers JE; Werkman TR; McCreary AC; Siarey R; Kruse CG; Wadman WJ
    Neuropharmacology; 2004 Mar; 46(4):504-10. PubMed ID: 14975674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.
    Gronier B; Rasmussen K
    Br J Pharmacol; 1998 Jun; 124(3):455-64. PubMed ID: 9647468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Shirayama Y; Hashimoto K; Routledge C; Hagan JJ; Ashby CR
    Synapse; 2004 Apr; 52(1):20-8. PubMed ID: 14755629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholecystokinin potentiates dopamine inhibition of mesencephalic dopamine neurons in vitro.
    Brodie MS; Dunwiddie TV
    Brain Res; 1987 Nov; 425(1):106-13. PubMed ID: 3427413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype.
    Hommer DW; Stoner G; Crawley JN; Paul SM; Skirboll LR
    J Neurosci; 1986 Oct; 6(10):3039-43. PubMed ID: 3760947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diet and chronic haloperidol effects on rat midbrain dopamine neurons.
    Hamilton ME; Freeman AS
    Synapse; 2004 Jul; 53(1):1-5. PubMed ID: 15150734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
    Crawley JN
    J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.